Diabetic Macular Edema Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 05
SKU : PH30
180 pages
Report Summary
Table of Contents
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Diabetic Macular Edema Market during the Forecast Period?
The diabetic Macular Edema market is expected to grow at a CAGR of 1.1% during the forecast period 2024-2031.
Who are the Key players contributing to the market's growth?
Key Players are Novartis AG, Roche, Allergan, Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., Pfizer Inc., Bayer AG, Bausch & Lomb Incorporated.
Related Reports
pharmaceuticalsXerophthalmia Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 January 06
Starting from
$4350
pharmaceuticalsOphthalmology Drugs and Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 22
Starting from
$4350
pharmaceuticalsMacular Degeneration Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 22
Starting from
$4350
pharmaceuticalsOptical Disorders Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 01
Starting from
$4350
pharmaceuticalsDry Eye Syndrome Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 11
Starting from
$4350
pharmaceuticalsIntravitreal (IVT) Injectable Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 March 11
Starting from
$4350